Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Sarcoma 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

cyclopia sequence 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 778Fluorouracil 637Capecitabine 573Gemcitabine 478Leucovorin 458Irinotecan 444Bevacizumab 443Cisplatin 337Radiotherapy 282Cetuximab 251Paclitaxel 180S 1 (combination) 175pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 130apatinib 130130-nm albumin-bound paclitaxel 127Folfox protocol 120durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106Surgical Procedures, Operative 102regorafenib 101Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Modafinil × Gastrointestinal × Clear all
NCT01746043 2018-06-06

A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
22 enrolled 11 charts
Gastrointestinal

cyclopia sequence, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡